Enrolling by invitationPhase 2NCT03948867

Stroke Prevention With Hydroxyurea Enabled Through Research and Education (SPHERE)

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Intervention
Hydroxyurea(drug)
Enrollment
202 enrolled
Eligibility
2-16 years · All sexes
Timeline
2019 – 2026

Study locations (2)

Collaborators

Bugando Medical Centre · The American Society of Hematology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03948867 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials